title: Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control.
abstract: Resistance to the hormones insulin and leptin are hallmarks in common for type 2 diabetes mellitus and obesity. Both conditions are associated with increased activity and expression of protein tyrosine phosphatase (PTP)1B. Therefore, inhibition of PTP1B activity or down-regulation of its expression should ameliorate insulin and leptin resistance, and may hold therapeutic utility in type 2 diabetes mellitus and obesity control. This background has motivated the fervent search for PTP1B inhibitors, carried out in the recent years. The purpose of this review is to provide the most recent advances in understanding the structural details of PTP1B molecule relevant to the interactions with inhibitors, and the progress towards compounds with enhanced membrane permeability, affinity, specificity, and potency on intracellular PTP1B; several inhibitors of benefit in type 2 diabetes mellitus and obesity control are presented and discussed.
authors.affiliation: Institute of Cellular Biology and Pathology N. Simionescu of the Romanian Academy 8, B.P. Hasdeu Street, 050568 Bucharest, Romania. doina.popov@icbp.ro
authors.forename: Doina
authors.initials: D
authors.lastname: Popov
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000737:chemistry* / Q000627:therapeutic use*; D006801:Humans; D007333:Insulin Resistance; D020738:Leptin / Q000494:pharmacology; D015394:Molecular Structure; D009765:Obesity / Q000188:drug therapy*; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1 / Q000037:antagonists & inhibitors* / Q000737:chemistry
chemical_list: D004791:Enzyme Inhibitors; D020738:Leptin; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1